Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells

Kidney Int. 2004 Jan;65(1):15-24. doi: 10.1111/j.1523-1755.2004.00379.x.

Abstract

Background: Despite increasing interest in bone marrow-derived stem cells, little is known about critical factors that determine their fates both in vitro and in vivo. Recently, we have reported that bone marrow is a reservoir for glomerular mesangial cells in rats. To find a key factor responsible for the differentiation of bone marrow-derived cells into mesangial cells, we established a new culture system of rat bone marrow, which is based on serial replating and differential attachment to collagen types I and IV.

Methods: Bone marrow cells that did not adhere to collagen type I within 24 hours were transferred to collagen type IV-coated dishes. Then, the cells attached to collagen type IV in the following 24 hours were maintained in the presence of 2% horse serum, 200 ng/mL of platelet-derived growth factor (PDGF)-BB, and 1 micromol/L of all-trans retinoic acid. In vivo effect of PDGF-B was also examined by introducing human PDGF-B gene into glomeruli.

Results: After cultivation under the above condition for 7 days, approximately 14% of cells expressed Thy-1 and desmin, both of which are markers for rat mesangial cells. Thy-1++/desmin+ cells were stellate-shaped, and contracted in response to angiotensin II. When human PDGF-B gene was overexpressed in the glomeruli of chimeric rats whose bone marrow was transplanted from enhanced green florescent protein (EGFP) transgenic rats, the number of EGFP+ mesangial cells increased. This effect was canceled by prior introduction of a neutralizing molecule that is composed of PDGF receptor-beta ligand binding site and IgG-Fc.

Conclusion: These results indicate that PDGF-B plays a critical role to direct bone marrow-derived cells toward mesangial-like cells both in vitro and in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Animals, Genetically Modified
  • Bone Marrow Cells / cytology*
  • Bone Marrow Cells / drug effects
  • Bone Marrow Cells / metabolism
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Cells, Cultured
  • Desmin / metabolism
  • Glomerular Mesangium / cytology*
  • Glomerular Mesangium / physiology
  • Green Fluorescent Proteins
  • In Vitro Techniques
  • Luminescent Proteins / genetics
  • Proto-Oncogene Proteins c-sis / genetics*
  • Proto-Oncogene Proteins c-sis / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Thy-1 Antigens / metabolism
  • Vasoconstrictor Agents / pharmacology

Substances

  • Desmin
  • Luminescent Proteins
  • Proto-Oncogene Proteins c-sis
  • Thy-1 Antigens
  • Vasoconstrictor Agents
  • Angiotensin II
  • Green Fluorescent Proteins